AGP Picks
View all

AGP Executive Report

Last update: 8 hours ago

Oncology Research: Poland’s Ryvu Therapeutics and Menarini announced initial clinical activity in a Phase II trial of dapolsertib for heavily pretreated aggressive B-cell lymphoma. More than half of participants had previously received CAR-T therapy; detailed results are due at the ASH meeting on Dec. 13.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
an hour ago

Nomono opens its audio engine to developers and AI agents

AGP

fallback image
2 hours ago

Top 10 environmental test chamber suppliers for 2026

AGP

fallback image
an hour ago

Top 10 automatic case packer companies for 2026

AGP

fallback image
Oct. 22, 2026

Poland moves toward joining HealthAI’s global AI health network

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Stream It Or Skip It: ‘Anaesthesia’ On Netflix, About A Neurosurgeon Who Tries To Revive His Career In A Small-Town Hospital

Stream It Or Skip It: ‘Anaesthesia’ On Netflix, About A Neurosurgeon Who Tries To Revive His Career In A Small-Town Hospital


fallback image
6 hours ago

121st Field Hospital Revives Korean War-Era Rail Evacuation With a Commercial Railcar

DVIDS - Georgia

fallback image
7 hours ago

Five Reputable Modular Medical Storage System Manufacturers in 2026: Advancing Flexible, Infection-Safe Infrastructure

EIN Presswire

fallback image
Nov. 4, 2026

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting

GlobeNewswire, Inc.

fallback image
an hour ago

Nomono Launches the Nomono Platform, Opening the Engine Behind Nomono Studio to Developers, Producers, and AI Agents

EIN Presswire

fallback image
an hour ago

TOP 10 AUTOMATIC CASE PACKER COMPANIES FOR 2026 INDUSTRY REVIEW

EIN Presswire

fallback image
2 hours ago

Top 10 Environmental Test Chamber Companies in 2026

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail: Current Judicial Crisis Is 'Weakening Poland', Says Jourová
Play
Current Judicial Crisis Is 'Weakening Poland', Says Jourová
YouTube video thumbnail: Polish Video Game Days 2026: The Witcher, Cyberpunk and 40 Years of Games
Play
Polish Video Game Days 2026: The Witcher, Cyberpunk and 40 Years of Games
YouTube video thumbnail: Discover Affinity Group Publishing
Play
Discover Affinity Group Publishing
YouTube video thumbnail: US Midterms: What Trump's Defeat Means for Europe and Global Markets
Play
US Midterms: What Trump's Defeat Means for Europe and Global Markets
YouTube video thumbnail:  'Hoax' Bomb Threats Trigger Flight Disruptions Across Europe
Play
'Hoax' Bomb Threats Trigger Flight Disruptions Across Europe

Video Title

Sign up for:

Poland Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Poland Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.